Search

Displaying all 2 results
  1. Drug

    Lenacapavir

    go.drugbank.com/drugs/DB15673
    ApprovedInvestigational

    [A244170, A244175, A244180, A244190] Lenacapavir was first globally approved on August 22, 2022 by the European Commission to treat adults with multi-drug resistant HIV infection. … [A244170, A244175] Lenacapavir is a first-in-class capsid inhibitor that demonstrates picomolar HIV-1 inhibition as a monotherapy _in vitro_, little to no cross-resistance with existing antiretroviral

    Synonyms: LenacapavirSalts: Lenacapavir sodium
  2. Drug

    Bictegravir

    go.drugbank.com/drugs/DB11799
    ApprovedInvestigational

    [L64114] It is not administered alone; it is available in fixed-dose combination tablets, with [tenofovir alafenamide] and [emtricitabine], and with [lenacapavir].[L50522, L64114]

    Salts: Bictegravir sodium